B cell lymphoma and myeloma in murine Gaucher's disease

Journal of Pathology

Volumn 231, Issue 1, 2013, Pages 88-97

  Pavlova, E V ^a   Wang, S Z ^a   Archer, J ^a   Dekker, N ^b   Aerts, J M F G ^b   Karlsson, S ^c   Cox, T M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gammopathy; Gaucher's disease; GBA1 deficiency; Glycosphingolipids; Lymphoma; Mouse immunoglobulins; Mx1 Cre conditional mouse model; Myeloma

Indexed keywords

GLUCOSYLCERAMIDASE; GLYCOSPHINGOLIPID; PARAPROTEIN; SYNDECAN 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CONTROLLED STUDY; EXON; GAUCHER DISEASE; HEMATOPOIETIC CELL; HOMOZYGOSITY; MACROPHAGE; MOLECULAR PATHOLOGY; MONOCLONAL IMMUNOGLOBULINEMIA; MOUSE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 84885139621     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4227     Document Type: Article

References (36)

1. Allen MJ, Myer BJ, Khokher AM, et al. Pro-inflammatory cytokines and the pathogenesis of Gaucher's disease: increased release of interleukin-6 and interleukin-10. Qu J Med 1997; 90(1): 19-25.
2. de Fost M, Out TA, de Wilde FA, et al. Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature. Ann Hematol 2008; 87(6): 439-449.
3. Benjamin D, Joshua H, Djaldetti M, et al. Nonsecretory IgD-? multiple myeloma in a patient with Gaucher's disease. Scand J Haematol 1979; 22: 179-184.
4. Fox H, McCarthy P, Andre-Schwartz J, et al. Gaucher's disease and chronic lymphocytic leukemia. Possible pathogenetic link between Gaucher's disease and B-cell proliferations? Cancer 1984; 54: 312-314.
5. Garfinkel D, Sidi Y, Ben Bassat M, et al. Coexistence of Gaucher's disease and multiple myeloma. Arch Intern Med 1982; 142: 2229-2230.
6. Harder H, Eucker J, Zang C, et al. Coincidence of Gaucher's disease due to a 1226G/1448C mutation and of an immunoglobulin G? multiple myeloma with Bence-Jones proteinuria. Ann Hematol 2000; 79: 640-643.
7. Mark T, Dominguez C, Rywlin AM. Gaucher's disease associated with chronic lymphocytic leukemia. South Med J 1982; 75: 361-363.
8. Pinkhas J, Djaldetti M, Yaron M. Coincidence of multiple myeloma with Gaucher's disease. Israel J Med Sci 1965; 1: 537-540.
9. Pratt PW, Kochwa S, Estren S. Immunoglobulin abnormalities in Gaucher's disease. Report of 16 cases. Blood 1968; 31: 633-640.
10. Ruestow PC, Levinson DJ, Catchatourian R, et al. Coexistence of IgA myeloma and Gaucher's disease. Arch Intern Med 1980; 140: 1115-1116.
11. de Fost M, Vom Dahl S, Weverling GJ, et al. Increased incidence of cancer in adult Gaucher disease in Western Europe. Blood Cells Mol Dis 2006; 36(1): 53-58.
12. Taddei TH, Kacena KA, Yang M, et al. The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients. Am J Hematol 2009; 84(4): 208-214.
13. Rosenbloom BE, Weinreb NJ, Zimran A, et al. Gaucher disease and cancer incidence: a study from the Gaucher Registry. Blood 2005; 105(12): 4569-4572.
14. Barak V, Acker M, Nisman B, et al. Cytokines in Gaucher's disease. Eur Cytokine Netw 1999; 10(2): 205-210.
15. Cox TM. Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis 2001; 24(suppl 2): 106-121, discussion 87-88.
16. Lichtenstein M, Zimran A, Horowitz M. Cytokine mRNA in Gaucher disease. Blood Cells Mol Dis 1997; 23(3): 395-401.
17. Boven LA, van Meurs M, Boot RG, et al. Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages. Am J Clin Pathol 2004; 122(3): 359-369.
18. Boot RG, Verhoek M, de Fost M, et al. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 2004; 103(1): 33-39.
19. Mizukami H, Mi Y, Wada R, et al. Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage. J Clin Invest 2002; 109(9): 1215-1221.
20. Dekker N, van Dussen L, Hollak CE, et al. Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. Blood 2011; 118(16): e118-127.
21. Kanazawa T, Nakamura S, Momoi M, et al. Inhibition of cytokinesis by a lipid metabolite, psychosine. J Cell Biol 2000; 149(4): 943-950.
22. Im DS, Heise CE, Nguyen T, et al. Identification of a molecular target of psychosine and its role in globoid cell formation. J Cell Biol 2001; 153(2): 429-434.
23. Enquist IB, Nilsson E, Ooka A, et al. Effective cell and gene therapy in a murine model of Gaucher disease. Proc Natl Acad Sci USA 2006; 103(37): 13819-13824.
24. Daniels LB, Glew RH. β-Glucosidase assays in the diagnosis of Gaucher's disease. Clin Chem 1982; 28(4, pt 1): 569-577.
25. Morse HC III, Anver MR, Fredrickson TN, et al. Hematopathology subcommittee of the Mouse Models of Human Cancers Consortium. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 2002; 100(1): 246-258.
26. Bethesda proposals for classification of lymphoid neoplasms in mice. Supplementary material for Morse et al. [25].
27. Cachon-Gonzalez MB, Wang SZ, Lynch A, et al. Effective gene therapy in an authentic model of Tay-Sachs-related diseases. Proc Natl Acad Sci USA 2006; 103(27): 10373-10378.
28. Ye BH, Lista F, Coco FL, et al. Alterations of a zinc finger-encoding gene, BCL-6 , in diffuse large-cell lymphoma. Science 1993; 262: 747-750.
29. Cattoretti G, Pasqualucci L, Ballon G, et al. Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. Cancer Cell 2005; 7(5): 445-455.
30. Brayton CF, Treuting PM, Ward JM. Pathobiology of aging mice and GEM: background strains and experimental design. Vet Pathol 2012; 49(1): 85-105.
31. Brigl M, Bry L, Kent , et al. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 2003: 4: 1230-1237.
32. Brennan PJ, Tatituri RV, Brigl M, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol 2011; 12(12): 1202-1211.
33. Liu J, Halene S, Yang M, et al. Gaucher disease gene GBA functions in immune regulation. Proc Natl Acad Sci USA 2012; 109(25): 10018-10023.
34. Mistry PK, Liu J, Yang M, et al. Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci USA 2010; 107(45): 19473-19478.
35. Turner SD, Tooze R, Maclennan K, et al. Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase. Oncogene 2003; 22(49): 7750-7761.
36. Corcoran AE, Riddell A, Krooshoop D, et al. Nature 1998; 391: 904-907.